ACE2 and COVID-19: Transaminase elevation in patients with COVID-19 may be caused by direct liver injury by SARS-CoV-2 via angiotensin-converting enzyme-2 in cholangiocytes, cytokine storm, or pneumonia-associated hypoxia [24,25].